UV-Filtering Test Chamber Window for Photostability Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current photostability testing methods overexpose drugs to ultraviolet light, leading to degradation and compromising the safety and efficacy of pharmaceutical products, necessitating separate setups for UV and visible light exposure to meet regulatory requirements.

Innovation Solution

A filter is integrated into a photostability testing chamber that limits ultraviolet light transmission while allowing visible light passage, maintaining temperature control through air circulation, enabling simultaneous exposure to both light types within a single setup.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a single light source is used for both UV and visible light exposure, then testing efficiency is improved, but UV light overexposure causes drug degradation

Engineering Contradiction:
Improvetesting efficiencyVSAvoidUV light overexposure
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

A UV-filtering window is introduced as an intermediary component between the light source and the sample. This window selectively transmits visible light while blocking excessive UV light, enabling simultaneous exposure to both UV and visible light without causing harmful overexposure. The window material (such as acrylic or glass with specific UV absorption properties) acts as a mediator that modifies the spectral composition of the light reaching the sample.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The spectral parameters of the light source are modified by selecting appropriate window materials with specific UV transmission characteristics. By changing the material properties of the chamber window (e.g., using acrylic instead of glass, or using glass with UV-absorbing coatings), the UV light transmission is reduced to appropriate levels while maintaining visible light transmission, thus resolving the overexposure issue.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If UV-filtering window is added to control UV exposure, then drug integrity is improved, but device complexity increases

Engineering Contradiction:
Improvedrug integrityVSAvoidchamber structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The chamber window serves multiple functions simultaneously: it acts as the enclosure boundary, provides optical transparency for light transmission, and functions as a UV filter. By selecting window materials with appropriate optical and filtering properties (such as acrylic or UV-absorbing glass), the same component accomplishes both structural and spectral control functions, avoiding the need for separate filtering elements.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The UV-filtering window can be implemented as a thin transparent layer or coating on the chamber wall. This thin-film approach maintains the structural integrity and transparency needed for optical access while providing effective UV filtering. The window material (acrylic, glass with coatings) forms a flexible yet functional barrier that integrates seamlessly into the chamber design.

Inventive Principle:
Principle #30Flexible shells and thin films

3Stability of the object's composition

If UV light exposure is reduced to meet ICH requirements, then photodegradation is prevented, but testing duration may increase

Engineering Contradiction:
Improvedrug stabilityVSAvoidtesting duration
Core Design Contradiction:
Stability of the object's compositionVSLoss of time

Solution Approach 1:

The UV-filtering window provides continuous spectral control during the entire exposure process, allowing the sample to receive appropriate UV and visible light doses simultaneously. This eliminates the need for sequential testing or extended exposure times, as the correct light composition is provided from the start, maintaining drug stability while completing testing efficiently.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The filter reduces ultraviolet light exposure by up to 98%, preventing drug degradation and maintaining temperature stability, thus ensuring compliance with regulatory standards and preserving the integrity of drug products.

Implementation Method 1

a filter that limits at least 30%, at least 50%, or at least 90% transmission of ultraviolet light

Methodology Applied
Scientific EffectAbsorption (EM radiation): Absorption (EM radiation)

Implementation Method 2

Air circulation is another important function to maintain stability inside the light chamber

Methodology Applied
Scientific EffectConvection: Convection

Data Source

PatentEP4302068B1Test chamber for photostability testing
Publication Date: 2026.02.11 LONZA AG
  • EP4302068B1 patent drawingFigure 1
  • EP4302068B1 patent drawingFigure 2
  • EP4302068B1 patent drawingFigure 3A

AI summary

The present disclosure provides an ultraviolet light filter for use in photostability testing chambers, and in particular, filters that are designed to allow for air ventilation and maintenance of desired temperatures at the sample level during light exposure testing.